Multitarget Therapeutic Leads for Alzheimer's Disease : Quinolizidinyl Derivatives of Bi- and Tricyclic Systems as Dual Inhibitors of Cholinesterases and β-Amyloid (Aβ) Aggregation
Articolo
Data di Pubblicazione:
2015
Citazione:
Multitarget Therapeutic Leads for Alzheimer's Disease : Quinolizidinyl Derivatives of Bi- and Tricyclic Systems as Dual Inhibitors of Cholinesterases and β-Amyloid (Aβ) Aggregation / M. Tonelli, M. Catto, B. Tasso, F. Novelli, C. Canu, G. Iusco, L. Pisani, A.D. Stradis, N. Denora, A. Sparatore, V. Boido, A. Carotti, F. Sparatore. - In: CHEMMEDCHEM. - ISSN 1860-7179. - 10:6(2015 Jun), pp. 1040-1053.
Abstract:
Multitarget therapeutic leads for Alzheimer's disease were designed on the models of compounds capable of maintaining or restoring cell protein homeostasis and of inhibiting β-amyloid (Aβ) oligomerization. Thirty-seven thioxanthen-9-one, xanthen-9-one, naphto- and anthraquinone derivatives were tested for the direct inhibition of Aβ(1-40) aggregation and for the inhibition of electric eel acetylcholinesterase (eeAChE) and horse serum butyrylcholinesterase (hsBChE). These compounds are characterized by basic side chains, mainly quinolizidinylalkyl moieties, linked to various bi- and tri-cyclic (hetero)aromatic systems. With very few exceptions, these compounds displayed inhibitory activity on both AChE and BChE and on the spontaneous aggregation of β-amyloid. In most cases, IC50 values were in the low micromolar and sub-micromolar range, but some compounds even reached nanomolar potency. The time course of amyloid aggregation in the presence of the most active derivative (IC50 =0.84μM) revealed that these compounds might act as destabilizers of mature fibrils rather than mere inhibitors of fibrillization. Many compounds inhibited one or both cholinesterases and Aβ aggregation with similar potency, a fundamental requisite for the possible development of therapeutics exhibiting a multitarget mechanism of action. The described compounds thus represent interesting leads for the development of multitarget AD therapeutics.
Tipologia IRIS:
01 - Articolo su periodico
Keywords:
Amyloid-beta; Cholinesterases; Multitarget agents; Quinolizidines; Quinonic derivatives; Thioxanthenones; Pharmacology, Toxicology and Pharmaceutics (all); Organic Chemistry; Molecular Medicine
Elenco autori:
M. Tonelli, M. Catto, B. Tasso, F. Novelli, C. Canu, G. Iusco, L. Pisani, A.D. Stradis, N. Denora, A. Sparatore, V. Boido, A. Carotti, F. Sparatore
Link alla scheda completa: